GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Benefytt Technologies Inc (NAS:BFYT) » Definitions » Intrinsic Value: Projected FCF

Benefytt Technologies (Benefytt Technologies) Intrinsic Value: Projected FCF : $0.00 (As of May. 11, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Benefytt Technologies Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-11), Benefytt Technologies's Intrinsic Value: Projected FCF is $0.00. The stock price of Benefytt Technologies is $31.00. Therefore, Benefytt Technologies's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Benefytt Technologies's Intrinsic Value: Projected FCF or its related term are showing as below:

BFYT's Price-to-Projected-FCF is not ranked *
in the Healthcare Plans industry.
Industry Median: 0.77
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Benefytt Technologies Intrinsic Value: Projected FCF Historical Data

The historical data trend for Benefytt Technologies's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benefytt Technologies Intrinsic Value: Projected FCF Chart

Benefytt Technologies Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only - - 15.81 18.65 12.65

Benefytt Technologies Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.73 14.36 12.65 6.72 5.66

Competitive Comparison of Benefytt Technologies's Intrinsic Value: Projected FCF

For the Healthcare Plans subindustry, Benefytt Technologies's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Benefytt Technologies's Price-to-Projected-FCF Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Benefytt Technologies's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Benefytt Technologies's Price-to-Projected-FCF falls into.



Benefytt Technologies Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Benefytt Technologies's Free Cash Flow(6 year avg) = $1.31.

Benefytt Technologies's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Jun20)*0.8)/Shares Outstanding (Diluted Average)
=(12.608723088515*1.31296+66.66*0.8)/12.353
=5.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Benefytt Technologies  (NAS:BFYT) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Benefytt Technologies's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=31.00/5.6571479856146
=5.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Benefytt Technologies Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Benefytt Technologies's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Benefytt Technologies (Benefytt Technologies) Business Description

Traded in Other Exchanges
N/A
Address
3450 Buschwood Park Drive, Suite 200, Tampa, FL, USA, 33618
Benefytt Technologies Inc is a health insurance technology company. It is engaged in the development and operation of private e-commerce health insurance marketplaces, consumer engagement platforms, agency technology systems, and insurance policy administration platforms. Its reportable segments are Medicare and IFP. The Medicare segment consists of consumer engagement activities which generate leads that the company sells to third-parties whereas, the IFP segment focuses on the sale and service of individual and family health insurance plans which includes short-term medical insurance plans and health benefit insurance plans. The firm also offers supplemental products which include additional insurance and non-insurance products.
Executives
Peggy Scott director 15438 NORTH FLORIDA AVENUE, SUITE 201, TAMPA FL 33613
John Fichthorn director C/O DIALECTIC CAPITAL MANAGEMENT, LLC, 17 STATE STREET, SUITE 3930, NEW YORK NY 10004
Robert S Murley director 4025 S. RIVERPOINT PARKWAY, M/S CF-K815, PHOENIX AZ 85040
Erik M Helding officer: Chief Financial Officer 11825 N. PENNSYLVANIA STREET, CARMEL IN 46032
Paul G Gabos director 19387 US 19 N, CLEARWATER FL 33764
Bruce Telkamp officer: CEO of HealthPocket, Inc.* 440 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Sheldon Wang officer: Chief Technology Officer 440 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Cannell Capital Llc 10 percent owner 245 MERIWETHER CIRCLE, ALTA WY 83414
Patrick Mcnamee director, officer: CEO and President C/O EXPRESS SCRIPTS, INC. 13900 RIVERPORT DRIVE MARYLAND HEIGHTS MO 63043
Dirk A Montgomery officer: EVP & Chief Financial Officer C/O HEALTH INSURANCE INNOVATIONS, INC., 15438 N. FLORIDA AVE., SUITE 201, TAMPA FL 33613
Gordon Tunstall director